Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Tenatoprazole-Na in Erosive or Ulcerative Esophagitis
NCT00282555Phase 2Suspended
- Sponsor
- Steba Biotech
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S-tenatoprazole in erosive esophagitis (EE) and esophagitis (5 arms), sponsored by Steba Biotech. Primary endpoint: Assessment of achievement of grade 'not present' in the Los Angeles scale of esophagitis at 2 weeks. Started Feb 2006; status: suspended.
02
Drugs
S-tenatoprazole
03
Conditions
erosive esophagitis (EE)esophagitis
Beyond the preview
Go deeper on NCT00282555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282555.